EP4487839A1 — Pharmaceutical dosage form comprising trientine tetrahydrochloride, and method for preparing the same
Assigned to Alfred E Tiefenbacher GmbH and Co KG · Expires 2025-01-08 · 1y expired
What this patent protects
The present invention relates to a pharmaceutical dosage form of trientine tetrahydrochloride that has low stickiness and good fluidity, and that can be stably manufactured. The pharmaceutical dosage form comprises crystalline trientine tetrahydrochloride and at least one pharmac…
USPTO Abstract
The present invention relates to a pharmaceutical dosage form of trientine tetrahydrochloride that has low stickiness and good fluidity, and that can be stably manufactured. The pharmaceutical dosage form comprises crystalline trientine tetrahydrochloride and at least one pharmaceutically acceptable excipient. Moreover, the present invention relates to a method of preparing the pharmaceutical dosage form.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.